Drugs / Danshen Decoction
last change Dec 2019 re-read 2 minutes ago

Danshen Decoction

Developed for
intermediate coronary syndrome
Investigated by
Jun Li · Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Trials 2 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03171597 Aug 2017 → Oct 2019 intermediate coronary syndrome Jun Li Unknown No outcome recorded
Phase 4 NCT03179514 Jul 2017 → Oct 2019 intermediate coronary syndrome Jun Li Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Danshen Decoction ClinicalTrials.gov intervention name — accepted as the source's own label NCT03179514
1

NCT03171597